T1	Participants 55 84	experimental human influenza:
T2	Participants 519 576	treatment of influenza in experimentally infected humans.
T3	Participants 710 748	2 large US university medical schools.
T4	Participants 762 919	A total of 117 healthy adult volunteers (aged 18-40 years; median age, 21 years) who were susceptible (hemagglutination-inhibition antibody titer < or =1:8).
T5	Participants 2957 2985	experimental human influenza
